Coronary Microvascular Disease (CMD) Registry

计划入组 1,000 人 · 首次发布于 2023 年 7 月 25 日

An Observational Study of Coronary Microvascular Disease of China

计划入组 500 人 · 首次发布于 2024 年 11 月 6 日

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

首次发布于 2020 年 6 月 4 日

liver disease program

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

Microvascular Therapeutics LLC

United States

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

Hourglass-Shaped Stent Shows Promise in Treating Refractory Angina

ADVANCE Trial Analysis: Intensive Glucose Control Benefits Type 2 Diabetes Patients Regardless of Disease Onset Age

FDA Reviewers Express Concerns Over Sotagliflozin's Safety for Type 1 Diabetes Patients with CKD